• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Bayer Ag S/Adr (OP:BAYRY)

    14.47 +0.89 (+6.55%)
    Streaming Delayed Price Updated: 12:35 PM EST, Feb 17, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,303,100
    Open 13.86
    Bid (Size) N/A (0)
    Ask (Size) N/A (0)
    Prev. Close 13.58
    Today's Range 13.77 - 14.85
    52wk Range 5.300 - 13.98
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Retina’s ‘Sustained’ Moment: Ocular Therapeutix Braces for Game-Changing Phase 3 AXPAXLI Data
    The multi-billion dollar wet Age-Related Macular Degeneration (wet AMD) market is standing on the precipice of a transformative shift. Today, February 16, 2026, Ocular Therapeutix (NASDAQ: OCUL) is in... 
    Via MarketMinute
    News headline image
    Bayer® Aspirin Partners with Celebrity Chef Jeff Mauro for Immersive Dark Dining Experience This American Heart Month
    From Bayer
    Via Business Wire

    Performance

    YTD
    +30.5%
    +30.5%
    1 Month
    +15.7%
    +15.7%
    3 Month
    +80.6%
    +80.6%
    6 Month
    +80.4%
    +80.4%
    1 Year
    +153.0%
    +153.0%

    More News

    Read More
    News headline image
    Bayer’s Asundexian Demonstrated a Substantial 26% Reduction in Stroke After a Non-Cardioembolic Ischemic Stroke or High-Risk Transient Ischemic Attack, With No Increase in ISTH Major Bleeding Versus Placebo
    From Bayer
    Via Business Wire
    News headline image
    Bayer Teams Up with Former Professional Quarterback Tony Romo on ‘Highlights REAL’ Campaign
    From Bayer
    Via Business Wire
    News headline image
    Bayer to Present Results From Phase III OCEANIC-STROKE Study of Asundexian in Secondary Stroke Prevention
    From Bayer
    Via Business Wire
    News headline image
    Wall Street’s ‘Fear Gauge’ Reclaims the 20 Mark: Why the Greenland Tariff Threat and Earnings Redlining Triggered a Market Reset
    Via MarketMinute
    Topics Economy Government Stocks
    Bayer Stock Fuels Hyper Bullish Retail Mood After Confirming New Stroke Study Met Key Goals Following 2023 Halt ↗
    Via Stocktwits
    News headline image
    Bayer and Vanderbilt University Medical Center to Advance Treatments for Cardiovascular and Kidney Diseases
    From Bayer
    Via Business Wire
    News headline image
    The mRNA 2.0 Inflection: A Deep Dive into Moderna (MRNA) as it Faces a Critical 2026
    Via Finterra
    Topics Initial Public Offering Intellectual Property Lawsuit
    News headline image
    Bayer Accelerates Pharma Growth on High-Value Portfolio
    From Bayer
    Via Business Wire
    News headline image
    Actress and Menopause Advocate Gabrielle Union-Wade Partners with Bayer in the Lynkuet® (elinzanetant) ‘Life Doesn’t Stop for a Hot Flash’ Campaign for Moderate to Severe Hot Flashes Due to Menopause
    From Bayer
    Via Business Wire
    News headline image
    Bayer to Expand Into Molecular Imaging With Acquisition of Innovative Pan-Amyloid Radiotracers From Attralus
    From Bayer
    Via Business Wire
    News headline image
    Bayer and Soufflé Therapeutics Announce Strategic Collaboration to Advance Cell-Specific Heart-Targeted siRNA Therapy
    From Bayer
    Via Business Wire
    News headline image
    Bayer to Present Updates on Pharma Growth Strategy and Pipeline Advancements at J.P. Morgan’s 44th Annual Healthcare Conference
    From Bayer
    Via Business Wire
    News headline image
    Beyond the Bailout: US Farm Groups Demand Structural Reform as USDA Unveils $12 Billion 'Bridge' Program
    Via MarketMinute
    Topics Economy Energy
    News headline image
    Bayer Starts Phase IIa Study for Treatment of Patients With Alport Syndrome
    From Bayer
    Via Business Wire
    News headline image
    RSNA25: Pediatric Study for Bayer's Investigational MRI Contrast Agent Gadoquatrane Meets Primary and Secondary Endpoints
    From Bayer
    Via Business Wire
    News headline image
    Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia
    From Bayer
    Via Business Wire
    News headline image
    Bayer’s MEDRAD® Centargo Multi-Patient CT Injection System Now With A Wider Range of Compatible CT Contrast Agents and Presentations
    From Bayer
    Via Business Wire
    News headline image
    Bayer’s Asundexian Met Primary Efficacy and Safety Endpoints in Landmark Phase III OCEANIC-STROKE Study in Secondary Stroke Prevention
    From Bayer
    Via Business Wire
    News headline image
    FDA Signs Off On Bayer's New Lung Cancer Drug — Early Results Look Promising ↗
    Via Benzinga
    News headline image
    U.S. FDA Approves HYRNUO® (sevabertinib) for Previously Treated Patients with HER2-Mutated Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
    From Bayer
    Via Business Wire
    News headline image
    Siemens Warns Currency Headwinds Will Hit 2026 Results; CEO Defends Mid-Term Target ↗
    Via Benzinga
    News headline image
    Daré Bioscience (DARE) Q3 2025 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Agricultural Conglomerate Bayer Confident In Long-Term Outlook Despite Litigation Risks ↗
    Via Benzinga

    Frequently Asked Questions

    Is Bayer Ag S/Adr publicly traded?
    Yes, Bayer Ag S/Adr is publicly traded.
    What exchange does Bayer Ag S/Adr trade on?
    Bayer Ag S/Adr trades on the OTC Traded
    What is the ticker symbol for Bayer Ag S/Adr?
    The ticker symbol for Bayer Ag S/Adr is BAYRY on the OTC Traded
    What is the current price of Bayer Ag S/Adr?
    The current price of Bayer Ag S/Adr is 14.47
    When was Bayer Ag S/Adr last traded?
    The last trade of Bayer Ag S/Adr was at 02/17/26 12:35 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.